Tracking cancer drugs in living cells by thermal profiling of the proteome
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Mapping human drug targets in the cell: To understand both the beneficial and the side effects of a drug, one would need to know its full binding profile to all cellular proteins. Savitski et al. take significant steps toward meeting this daunting challenge. They monitored the unfolding or “melting” of over 7000 human proteins and measured how small-molecule binding changes individual melting profiles. As a proof of principle, over 50 targets were identified for an inhibitor known to bind a broad spectrum of kinases. Two cancer drugs, vemurafib and Alectinib, are known to have a side effect of photosensitivity. The thermal profiling approach identified drug-protein interactions responsible for these side effects. Science , this issue 10.1126/science.1255784
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thermal proteome profiling (TPP, Savitski et al, 2014) is a mass-spectrometry (MS) based functional proteomics method that can identify shifts in protein thermal stability across different conditions (Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Especially in combination with quantitative changes measured by e.g., phosphoproteomics, TPP can be used to identify functionally relevant alterations and link them to signaling and phenotypic consequences (Savitski et al, 2014; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“TPP has been used successfully in the past for drug profiling, but it generates complex data that are difficult to interpret and potentially benefit from integration with other data types (Savitski et al, 2014; Perrin et al, 2020; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Thermal stabilization (i) is leveraged in thermal proteomics profiling (TPP), an approach that has been employed to, for instance, identify the ferrochelatase FECH as a frequent off-target of kinase inhibitors,224 or to uncover leucine aminopeptidase 3 as an off-target of several HDAC inhibitors.225”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [224]
In the citing paper
“This assay is based on the concept that binding of a compound to a protein can result in thermal stabilization of the protein and-consequently-in a detectable shift of its melting curve.”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Savitski et al., 2014
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Self-citationDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Bollag, G., Hirth, P., Tsai, J., Zhang, J., Ibrahim, P. N., Cho, H., Spevak, W., Zhang, C., Zhang, Y., Habets, G., et al. (2010) · Nature · doi:10.1038/nature09454 · Cited by 1,831
Mass-spectrometry-based draft of the human proteome
Wilhelm, M., Schlegl, J., Hahne, H., Gholami, A. M., Lieberenz, M., Savitski, M. M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., et al. (2014) · Nature · doi:10.1038/nature13319 · Cited by 1,820
Self-citationOverriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Shah, N. P., Tran, C., Lee, F. Y., Chen, P., Norris, D., & Sawyers, C. L. (2004) · Science · doi:10.1126/science.1099480 · Cited by 1,796
Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N., & Mann, M. (2014) · Nature Methods · doi:10.1038/nmeth.2834 · Cited by 1,719
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Self-citation
Cited by
Items 601–700 of 1,004
Johnson, F. D., Hughes, C. S., Liu, A., Lockwood, W. W., & Morin, G. B. (2023) · STAR Protocols · doi:10.1016/j.xpro.2022.102012 · Cited by 10
“BEFORE YOU BEGIN The TPP approach builds on the principle of the cellular thermal shift assay and the knowledge that, when heated, proteins will denature and become insoluble in a way that is dependent on their biophysical properties in solution.(2,3) TPP relies on the phenomenon in which the temperature required to d…”
BackgroundMethodGuanylate-binding protein 1 modulates proteasomal machinery in ovarian cancer
Tailor, D., Garcia-Marques, F. J., Bermudez, A., Pitteri, S. J., & Malhotra, S. V. (2023) · iScience · doi:10.1016/j.isci.2023.108292 · Cited by 12
Quantification of Binding of Small Molecules to Native Proteins Overexpressed in Living Cells
Yin, Y., Zhao, L., Rane, D., Lin, Z., Wu, M., & Peterson, B. R. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c07488 · Cited by 10
Ligand Modification-Free Methods for the Profiling of Protein-Environmental Chemical Interactions
Li, Y., Lyu, J., Wang, Y., Ye, M., & Wang, H. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00282 · Cited by 10
Xu, X., Yin, K., Xu, S., Wang, Z., & Wu, R. (2024) · Expert Review of Proteomics · doi:10.1080/14789450.2024.2314148 · Cited by 11
“Several methods such as cross-linking mass spectrometry (XL-MS) [86], thermal proteome profiling (TPP) [87], and co-fractionation mass spectrometry (coFrac-MS) [88] were reported to study protein-protein interactions (PPIs).”
MethodMitochondria: great balls of fire
Jacobs, H. T., Rustin, P., Bénit, P., Davidi, D., & Terzioglu, M. (2024) · FEBS Journal · doi:10.1111/febs.17316 · Cited by 12
Ryu, G., Ko, M., Lee, S.-Y., Park, S. I., Choi, J. W., Lee, J. Y., Kim, J. Y., & Kwon, H. J. (2024) · Biomolecules · doi:10.3390/biom14121505 · Cited by 10
Li, Y., Wu, Y., Liang, J., Chen, P., Xu, S., Wang, Y., Jiang, Z., Zhu, X., Lin, C., Yu, Y., et al. (2025) · Research · doi:10.34133/research.0864 · Cited by 10
“Following incubation, protein solution was aliquoted into 8 EP tubes and heated at the specified gradient temperatures (43, 46, 49, 52, 55, 58, 61, and 64 °C) for 3 min.”
Bioinformatics toolbox for exploring target mutation-induced drug resistance
Huang, Y., Sun, P., Chen, Y., Liu, H., Hao, G., & Song, B.-A. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad033 · Cited by 10
Ma, T. P., Izrael-Tomasevic, A., Mroue, R. M., Budayeva, H. G., Malhotra, S., Raisner, R. M., Evangelista, M., Rose, C. M., Kirkpatrick, D. S., & Yu, K. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00703 · Cited by 8
Deciphering Drug Targets and Actions with Single-Cell and Spatial Resolution
Pang, Z., Cravatt, B. F., & Li, Y. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-033123-123610 · Cited by 13
Lyu, H., Fu, C., Chai, X., Gong, Z., Zhang, J., Wang, J., Wang, J., Dai, L., & Xu, C. (2023) · Cell Systems · doi:10.1016/j.cels.2023.08.003 · Cited by 14
Griffith-Jones, S., Álvarez, L., Mukhopadhyay, U., Gharbi, S., Rettel, M., ADAMS, M. A., Hennig, J., & Bhogaraju, S. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00058-9 · Cited by 14
“Further parameters were set: Trypsin as protease with an allowance of maximum two missed cleavages and a minimum peptide length of seven amino acids was required.”
MethodInfluentialPerturbation-Based Proteomic Correlation Profiling as a Target Deconvolution Methodology
Ohki, Y., Sakurai, H., Hoshino, M., Terashima, H., Shimizu, H., ISHIKAWA, T., Ogiyama, T., Muramatsu, Y., Nakanishi, T., Miyazaki, S., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.10.012 · Cited by 10
Mechanistic Basis of Cabotegravir–Glucuronide Disposition in Humans
Patel, M., Eberl, H. C., Wolf, A., Pierre, E., Polli, J. W., & Zamek‐Gliszczynski, M. J. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258384 · Cited by 11
“…(OAT1, OAT3, and OAT4) levels in HEK cells and tissues by mass spectrometric analysis, about 25 mg total protein per sample was in gel digested and labeled with isobaric mass tags, and samples were separated into 25 fractions by high-pH reverse-phase chromatography (Savitski et al., 2014).”
MethodInteraction profiling methods to map protein and pathway targets of bioactive ligands
Huang, J., Coukos, J. S., & Moellering, R. E. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.02.001 · Cited by 10
Coutinho, J. V. P., Rosa-Fernandes, L., Mule, S. N., de Oliveira, G. S., Manchola, N. C., Santiago, V. F., Colli, W., Wrenger, C., Alves, M. J. M., & Palmisano, G. (2021) · Journal of Proteomics · doi:10.1016/j.jprot.2021.104339 · Cited by 10
Structural Alternation in Heat Shock Proteins of Activated Macrophages
Zhang, W., Wei, Y., Zhang, H., Liu, J., Zong, Z., Liu, Z., Zhu, S., Hou, W., Chen, Y., & Deng, H. (2021) · Cells · doi:10.3390/cells10123507 · Cited by 10
“The CETSA experiment was performed according to the published method [17,18].”
MethodPACTS-Assisted Thermal Proteome Profiling for Use in Identifying Peptide-Interacting Proteins
Zhao, T., Tian, J., Wang, X., Hao, Y., Xu, M., Zhao, Y., Liu, X., Chen, Y., & Jia, C. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c00581 · Cited by 10
Marín‐Rubio, J. L., Heap, R. E., Dueñas, M. E., Heunis, T. D. J., Dannoura, A., Inns, J., Scott, J., Simpson, A. J., Blair, H. J., Heidenreich, O. T., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00671 · Cited by 12
Melting Down Protein Stability: PAPS Synthase 2 in Patients and in a Cellular Environment
Brylski, O., Ebbinghaus, S., & Mueller, J. W. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00031 · Cited by 10
“A pioneering study in this regard reported thermal profiling of the cellular proteome (Savitski et al., 2014).”
BackgroundAntibiotics that Kill Gram-negative Bacteria by Restructuring the Outer Membrane Protein BamAPreprint
Modaresi, S. M., Sugiyama, R., Tram, N. D. T., Jakob, R. P., Phan, C., Saei, A. A., Morishita, Y., Mühlethaler, T., Lim, J. L., Ritz, D., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.16.628070 · Cited by 16
The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2Preprint
Suryawanshi, R. K., Jaishankar, P., Correy, G. J., Rachman, M. M., O’Leary, P. C., Taha, T. Y., Matsui, Y., Belinchón, F. J. Z., McCavitt-Malvido, M., Doruk, Y. U., et al. (2025) · eLife · doi:10.7554/elife.103484 · Cited by 31
“Lastly, we used mass spectrometry-based thermal proteome profiling (TPP) ( Savitski et al., 2014 ) to evaluate the selectivity of AVI-4206 against a complex proteome.”
Jandu, R. S., Bhattacharya, A., Antony, F., Al‐Seragi, M., Aoki, H., Babu, M., & Duong, F. (2025) · eLife · doi:10.7554/elife.104549.3 · Cited by 13
Warrier, T., Romano, K. P., Clatworthy, A. E., & Hung, D. T. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.04.006 · Cited by 9
Review of predicting protein stability changes upon variations
Qiu, Y., Huang, T., & Cai, Y. (2024) · PROTEOMICS · doi:10.1002/pmic.202300371 · Cited by 15
Chandía-Cristi, A., Gutiérrez, D. A., Dulcey, A. E., Lara, M., Vargas, L., Lin, Y.-H., Jimenez-Muñoz, P., Larenas, G., Xu, X., Wang, A. Y., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114144 · Cited by 9
Smith, C. F., Modahl, C. M., Galindo, D. C., Larson, K. Y., Maroney, S. P., Bahrabadi, L., Brandehoff, N., Perry, B. W., McCabe, M. C., Petras, D., et al. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100779 · Cited by 10
The role of Nα‐terminal acetylation in protein conformation
Calis, S., & Gevaert, K. (2024) · FEBS Journal · doi:10.1111/febs.17209 · Cited by 13
Proteomic strategies to interrogate the Fe-S proteome
Bak, D. W., & Weerapana, E. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119791 · Cited by 10
Kim, D., & Nita‐Lazar, A. (2024) · Journal of Proteins and Proteomics · doi:10.1007/s42485-024-00156-6 · Cited by 11
“TPP is based on the cellular thermal shift assay (CETSA), which measures the thermal stability of proteins in intact cells or lysates by assessing their susceptibility to thermal denaturation and aggregation (Savitski et al. 2014).”
Zou, Y., Huang, C., Sturrock, G. R., Kelleher, N. L., & Fitzgerald, M. C. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04469 · Cited by 11
Crossovers are regulated by a conserved and disordered synaptonemal complex domain
Neves, A. R. R., Čavka, I., Rausch, T., & Köhler, S. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf095 · Cited by 13
Target discovery-directed pharmacological mechanism elucidation of bioactive natural products
Zhen, Z., Yin, L., Niu, T., Rehman, A., Liu, Y., & Zeng, K. (2025) · Medical Review · doi:10.1515/mr-2024-0076 · Cited by 15
Rüegger, J., Gagestein, B., Janssen, A. P. A., Valeanu, A., Mori, A. L., van der Peet, M., Boutkan, M. S., Florea, B. I., Henneman, A. A., Hochstrasser, R., et al. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.100961 · Cited by 10
Dai, G., Yang, Y., Mu, W., Li, Y., & Tu, Y. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156735 · Cited by 9
Tan, X., Wang, D., Yao, Y., Liu, K., Chen, Y., Fu, S., & Ni, F. (2025) · PROTEOMICS · doi:10.1002/pmic.70019 · Cited by 11
“These probe-free methods include techniques such as thermal proteome profiling (TPP/CETSA) [5, 6], drug affinity responsive target stability (DARTS) [7], stability of proteins from rates of oxidation (SPROX) [8], and limited proteolysis-mass spectrometry (LiP-MS) [9].”
Mapping cellular targets of covalent cancer drugs in the entire mammalian body
Pang, Z., Leung, V. H., Wang, C. C., Attarpour, A., Rinaldi, A., Shen, H., Moya-Garzón, M. D., Sigua, L. H., Rammel, C., Selke, A., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.030 · Cited by 10
“Although molecular target identification strategies, such as chemoproteomics, 1–5 chemogenomics, 6–9 and thermal shift profiling, 10–13 have revolutionized our understanding of drug activities, mapping in vivo drug targets with spatial and cellular resolution remains challenging.”
Chemoproteomic Profiling of Covalent XPO1 Inhibitors to Assess Target Engagement and Selectivity
Martin, J. G., Ward, J. A., Feyertag, F., Zhang, L., Couvertier, S. M., Guckian, K. M., Huber, K., & Johnson, D. S. (2021) · ChemBioChem · doi:10.1002/cbic.202100038 · Cited by 9
Martín‐Gago, P., Fansa, E. K., Klein, C. H., Murarka, S., Janning, P., Schürmann, M., Metz, M., Ismail, S., Schultz‐Fademrecht, C., Baumann, M., et al. (2017) · Angewandte Chemie · doi:10.1002/ange.201610957 · Cited by 10
Protein interactome of 3′,5′‐cAMP reveals its role in regulating the actin cytoskeleton
Figueroa, N. E., Franz, P., Luzarowski, M., Martínez-Seidel, F., Moreno, J. C., Childs, D., Ziemblicka, A., Sampathkumar, A., Andersen, T. G., Tsiavaliaris, G., et al. (2023) · The Plant Journal · doi:10.1111/tpj.16313 · Cited by 9
Mathay, M., Keller, A., & Bruce, J. E. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04501 · Cited by 9
Stincone, P., Naimi, A., Saviola, A. J., Reher, R., & Petras, D. (2023) · PROTEOMICS · doi:10.1002/pmic.202200533 · Cited by 11
“A second group of methods takes advantage of reduced thermal denaturation of the stabilized ligand-proteins complex [27, 56, 57].”
BackgroundMüller, J., Boubaker, G., Müller, N., Uldry, A., Braga-Lagache, S., Heller, M., & Hemphill, A. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136903 · Cited by 7
Novel Molecular Challenges in Targeting Anaplastic Lymphoma Kinase in ALK-Expressing Human Cancers
Alshareef, A. (2017) · Cancers · doi:10.3390/cancers9110148 · Cited by 11
“A few studies have used the CETSA assay to evaluate crizotinib treatment [32,84,85].”
MethodAffinity Enrichment Chemoproteomics for Target Deconvolution and Selectivity Profiling
Werner, T., Steidel, M., Eberl, H. C., & Bantscheff, M. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1024-4_17 · Cited by 9
Self-citationLizano-Fallas, V., del Amor, A. C., & Cristóbal, S. (2021) · Journal of Proteomics · doi:10.1016/j.jprot.2021.104382 · Cited by 10
Identifying Protein–Drug Interactions in Cell Lysates Using Histidine Hydrogen Deuterium Exchange
Miyagi, M., Tanaka, K., Watanabe, S., Kondo, J., & Kishimoto, T. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c02283 · Cited by 9
Lenz, T., & Stühler, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105605 · Cited by 9
Ko, M., Jung, H., Lee, D., Jeon, J., Kim, J., Baek, S., Lee, J. Y., Kim, J. Y., & Kwon, H. J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115776 · Cited by 9
Are Label-Free Investigations the Best Approach to Drug Discovery?
Ye, F. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.84 · Cited by 9
Non-stoichiometric inhibition in integrated lead finding – a literature review
Klumpp, M. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1128892 · Cited by 11
“targets [133] seems particularly promising, and this”
Strategies in functional proteomics: Unveiling the pathways to precision oncology
Favicchio, R., Thepaut, C., Zhang, H., Arends, R., Stebbing, J., & Giamas, G. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.049 · Cited by 10
Target Engagement of Small Molecules: Thermal Profiling Approaches on Different Levels
Reckzeh, E. S., Brockmeyer, A., Metz, M., Waldmann, H., & Janning, P. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8891-4_4 · Cited by 9
System-wide identification and prioritization of enzyme substrates by thermal analysis (SIESTA)Preprint
Saei, A. A., Beusch, C. M., Sabatier, P., Wells, J. A., Chernobrovkin, A., Rodin, S., Näreoja, K., Thorsell, A.-G., Karlberg, T., Cheng, Q., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/423418 · Cited by 10
“Therefore, proteomewide monitoring of the thermal stability changes (19) in the cell lysate upon addition of a recombinant enzyme and an eventual cofactor has the potential to reveal enzyme substrates.”
BackgroundTowards a systematic map of the functional role of protein phosphorylationPreprint
Viéitez, C., Busby, B. P., Ochoa, D., Mateus, A., Galardini, M., Jawed, A., Memon, D., Potel, C. M., Vonesch, S. C., Szu‐Tu, C., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/872770 · Cited by 9
“Two-dimensional thermal proteome profiling (2D-TPP) The 2D-TPP protocol (Savitski et al, 2014) was adapted to be compatible with S.cerevisiae.”
MethodSelf-citationNetwork integration of thermal proteome profiling with multi-omics data decodes PARP inhibition
Burtscher, M. L., Gade, S., Garrido-Rodriguez, M., Rutkowska, A., Werner, T., Eberl, H. C., Petretich, M., Knopf, N., Zirngibl, K., Grandi, P., et al. (2024) · Molecular Systems Biology · doi:10.1038/s44320-024-00025-w · Cited by 7
“Thermal proteome pro fi ling (TPP, Savitski et al, 2014) is a mass-spectrometry (MS) based functional proteomics method that can identify shifts in protein thermal stability across different conditions (Mateus et al, 2020).”
BackgroundMethodInfluentialSelf-citationXu, D. D., Zhou, D., Bum‐Erdene, K., Bailey, B. J., Sishtla, K. L., Liu, S., Wan, J., Aryal, U. K., Lee, J. A., Wells, C. D., et al. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00078 · Cited by 8
Hoermann, B., Dürr, E., Ludwig, C., Ercan, M., & Köhn, M. (2024) · Chemical Science · doi:10.1039/d3sc04746f · Cited by 9
“Mass spectrometry (MS)-based technologies to study targets of drugs such as kinobeads, 15 thermal proteome pro ling (TPP), 16 or the recent pH-dependent protein precipitation (pHDPP) approach 17 cannot address these complex questions.”
BackgroundTóth, D., Tengölics, R., Aarabi, F., Karlsson, A., Vidal‐Meireles, A., Kovács, L., Kuntam, S., Körmöczi, T., Fernie, A. R., Hudson, E. P., et al. (2024) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiae409 · Cited by 12
“In thermal proteome profiling (TPP), protein stability is monitored through changes in solubility at different temperatures (Savitski et al. 2014; Mateus et al. 2020).”
BackgroundMeng, Z., Saei, A. A., Lyu, H., Gaetani, M., & Zubarev, R. A. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c05127 · Cited by 8
“Thermal Proteome Profiling (TPP 13 ), also known as CETSA-MS 8 , is a method for identifying drug targets by measuring changes in the thermal stability of proteins in a proteome-wide manner.”
Yu, C., Adavikolanu, R., Kaake, R. M., & Huang, L. (2025) · Mass Spectrometry Reviews · doi:10.1002/mas.21926 · Cited by 10
“The melting profile can change upon drug binding, typically showing thermal stabilization (Savitski et al. 2014).”
Emodin mitigates rheumatoid arthritis through direct binding to TNF-α
Lu, D.-Y., Tian, X., Cao, T., Chen, S., Liu, C., Zheng, L., Zhou, M., Peng, X., Li, Y., & Liu, T. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1520281 · Cited by 9
Small-molecule probes based on natural products: Elucidation of drug-target mechanisms in stroke
Jin, X., Liu, S., Chen, S., Han, R., Sun, X., Wei, M., Chang, Y., Li, L., & Zhang, H. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101290 · Cited by 8
“TPP enables highly sensitive and high-throughput identi fi cation of potential drug targets and effector proteins in the cellular environment without assuming a target and is an essential tool for drug discovery [124].”
High-speed fluorescence lifetime imaging microscopy: techniques, applications, and prospects
Kanno, H., Li, F., Park, J., Endo, H., Niizuma, K., Gao, L., & Goda, K. (2025) · Biophotonics discovery. · doi:10.1117/1.bios.2.3.030901 · Cited by 8
Zhu, H., Wang, K., Li, K., Fang, Z., Zhou, J., Xue, L., & Ye, M. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00365 · Cited by 8
Emerging trends in chemoproteomics: Mapping the landscape of protein–metabolite interactions
Wan, N., Liu, C., Hao, H., & Ye, H. (2025) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2025.102631 · Cited by 8
(2025) · doi:10.1038/s41594-025-01699-y · Cited by 8
Self-citationDrug discovery through biophysical techniques: Methods and applications
Zhou, Y., Hu, H., Huang, Q., Tang, Y., & Liu, Y. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108947 · Cited by 11
Herneisen, A. L., & Lourido, S. (2021) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4207 · Cited by 10
Bizzarri, L., Steinbrunn, D., Quennesson, T., Lacour, A., Bianchino, G. I., Bravo, P., Chaignon, P., Lohse, J., Mäser, P., Seemann, M., et al. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00417 · Cited by 9
Wang, G., Ma, S., Song, H., Liang, Y., Li, X., Zhang, L., Lu, H., & Zhang, Y. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c08065 · Cited by 9
From genome to proteome: Looking beyond DNA and RNA in chronic lymphocytic leukemia
Thurgood, L. A., Chataway, T., Lower, K. M., & Kuss, B. J. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.01.001 · Cited by 11
Öztuğ, M., Kılınç, E., Akgöz, M., & Karagüler, N. G. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0115 · Cited by 8
“Thermal Proteome Profiling (TPP) is a novel methodology that enables proteome wide analysis of the thermostability of proteins (Childs et al., 2019; Franken et al., 2015; Mateus et al., 2017; Savitski et al., 2014).”
Callyspongiolide kills cells by inducing mitochondrial dysfunction via cellular iron depletion
Ha, J., & Park, S. B. (2021) · Communications Biology · doi:10.1038/s42003-021-02643-8 · Cited by 10
Ma, R., Johnson, J. H. R., Tang, Y., & Fitzgerald, M. C. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00653 · Cited by 8
Jain, K. K. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7431-3_13 · Cited by 11
Hsp40 Affinity to Identify Proteins Destabilized by Cellular Toxicant Exposure
Quanrud, G. M., Montoya, M. R., Mei, L., Awad, M. R., & Genereux, J. C. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04230 · Cited by 10
Quan, B., Bailey, M. A., Mantyh, J. B., Hsu, D. S., & Fitzgerald, M. C. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00045 · Cited by 8
The Golgi stacking protein GRASP55 is targeted by the natural compound prodigiosin
Berning, L., Lenz, T., Bergmann, A., Poschmann, G., Brass, H. U. C., Schlütermann, D., Friedrich, A., Mendiburo, M. J., David, C., Akgün, S., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01275-1 · Cited by 8
“2 originates from the original three parameter ( I max = 1, using normalized data) description [62] considering that four parameters ( I max as fitting parameter) have been shown to be more appropriate [48].”
BackgroundMethodInfluentialProteomic tools to study drug function
Mulder, C., Leijten, N. M., & Lemeer, S. (2018) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2018.05.002 · Cited by 8
Direct label-free methods for identification of target proteins in agrochemicals
Zhao, B., Liu, N., Chen, L., Geng, S., Fan, Z., & Xing, J. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.237 · Cited by 8
Probes for Photoaffinity Labelling of Kinases
Korovesis, D., Beard, H. A., Mérillat, C., & Verhelst, S. H. L. (2021) · ChemBioChem · doi:10.1002/cbic.202000874 · Cited by 8
Conservation of metabolic regulation by phosphorylation and non-covalent small-molecule interactions
Gruber, C., Diether, M., & Sauer, U. (2021) · Cell Systems · doi:10.1016/j.cels.2021.04.009 · Cited by 10
Chemical proteomics, an integrated research engine for exploring drug-target-phenotype interactions
Kwon, H. J., & Karuso, P. (2018) · Proteome Science · doi:10.1186/s12953-017-0129-x · Cited by 8
“Savistski and co-workers summarize the recent developments in thermal proteome profiling (TPP) [1].”
Kellie, J. F., Sikorski, T. W., An, B., Chen, Z., Moghieb, A. H., Busz, M., Szapacs, M. E., & Angel, T. E. (2019) · Bioanalysis · doi:10.4155/bio-2019-0191 · Cited by 8
Polypharmacology and Natural Products
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_15 · Cited by 7
Wu, Z., Fu, Z., Yu, X., & Chen, J. (2024) · Critical Reviews in Environmental Science and Technology · doi:10.1080/10643389.2024.2320753 · Cited by 7
“…be directly translated to the dissociation constant K d , since the degree of thermal stabilization by pollutants with a similar binding mode tends to depend on the stability of the protein in its unbound state, resulting in a poor correlation between these two parameters (Savitski et al., 2014).”
InfluentialWang, S., Lei, K., Lai, H., Liu, T., Du, L., Wu, S.-Y., Ye, X., Chiang, C., & Li, M. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00057 · Cited by 7
Improved drug target deconvolution with PISA‐DIA using an extended, overlapping temperature gradient
Emery‐Corbin, S. J., Yousef, J. M., Adhikari, S., Sumardy, F., Nhu, D., van Delft, M. F., Lessène, G., Dziekan, J. M., Webb, A. I., & Dagley, L. F. (2024) · PROTEOMICS · doi:10.1002/pmic.202300644 · Cited by 7
“Compatibility is the core strength of TPP, including with native state analysis in living cells [9, 10], cell lysates [11, 12], tissue, and biological fluids [13].”
Identification of Rocaglate Acyl Sulfamides as Selective Inhibitors of Glioblastoma Stem Cells
Wang, Z., Thakare, R., Chitale, S., Mishra, A. K., Goldstein, S. I., Fan, A. C., Li, R., Zhu, L. J., Brown, L. E., Cencic, R., et al. (2024) · ACS Central Science · doi:10.1021/acscentsci.4c01073 · Cited by 7
Bravo, P., Bizzarri, L., Steinbrunn, D., Lohse, J., Hirsch, A. K. H., Mäser, P., Rottmann, M., & Hahne, H. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00418 · Cited by 7
Gao, W., Li, J., Zhang, Y., Yuan, H., Li, K., Zhang, J., Han, L., Fan, Z., Chen, L., & Tang, L. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c08092 · Cited by 7
The mitochondrial intermembrane space – a permanently proteostasis-challenged compartment
Weith, M., Weiss, K., Stobbe, D., & Riemer, J. (2025) · Biological Chemistry · doi:10.1515/hsz-2025-0108 · Cited by 10
“…locally (at least temporally) elevated temperatures, thermal proteome pro fi ling (TPP), which allows proteome-wide determination of melting points (Savitski et al. 2014), revealed that proteins associated with the ETC possess notably higher melting points than usual, averaging around 60 ° C…”
Aldehoff, A. S., Karkossa, I., Broghammer, H., Krupka, S., Weiner, J., Goerdeler, C., Nuwayhid, R., Langer, S., Wabitsch, M., Rolle-Kampczyk, U. E., et al. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c01206 · Cited by 8
Advances in BRET probes for intracellular target engagement studies
Capener, J. L., Schwalm, M. P., Vasta, J. D., Michaud, A., Teske, K. A., Marsiglia, W. M., Huber, K., Dar, A. C., Knapp, S., Axtman, A. D., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-025-02103-y · Cited by 9
Elsässer, F., Florea, R., Räsch, F., Zedan, M., Şen, N.-E., Pflästerer, T., Kleele, T., Loewith, R., Weis, K., de Souza, N., et al. (2026) · Molecular Systems Biology · doi:10.1038/s44320-025-00182-6 · Cited by 12
“Thermal protein pro fi ling (TPP) identi fi es proteins that change stability under conditions of interest but does not provide structural information about which region(s) of a protein may be altered (Savitski et al, 2014).”
Zhu, Y., Zhang, J., Tu, P., Zeng, K., & Wang, L. (2026) · Targetome · doi:10.48130/targetome-0026-0015 · Cited by 8
Target Engagement Measures in Preclinical Drug Discovery: Theory, Methods, and Case Studies
Durham, T. B., & Wiley, M. R. (2017) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-50042-3_3 · Cited by 7
Bao, J., Wang, Y., Wang, S., Niu, D., Wang, Z., Li, R., Zheng, Y., Ishfaq, M., Wu, Z., & Li, J. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.972245 · Cited by 7
Metadata
- Authors
- Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., Kuster, B., Nordlund, P., Bantscheff, M., & Drewes, G.
- Affiliations
- GlaxoSmithKline (Germany) (DE)
- Karolinska Institutet (SE)
- German Cancer Research Center (DE)
- Department of Proteomics and Bioanalytics, Technische Universität München, Emil Erlenmeyer Forum 5, Freising, Germany.
- Division of Biophysics, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
- Corresponding author
- Savitski, Mikhail M.
- Reinhard, Friedrich B. M.
- Bantscheff, Marcus
- Drewes, Gerard
- ORCID
- Venue
- Science
- Published
- 2014-10-03
- Volume
- 346
- Issue
- 6205
- Pages
- 1255784-1255784
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2131321938
- Cited by
- 1,187
- References
- 41
- Citations by year
- 2026: 119 · 2025: 138 · 2024: 148 · 2023: 130 · 2022: 116 · 2021: 132 · 2020: 95 · 2019: 85 · 2018: 67 · 2017: 56 · 2016: 54 · 2015: 39 · 2014: 5
- FWCI
- 22.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › thermodynamics and calorimetric analyses
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Keywords
- thermal proteome profiling, drug-target engagement, protein thermal stability, kinase inhibitors, staurosporine, ferrochelatase, vemurafenib, alectinib, phototoxicity, dasatinib, BCR-ABL, cancer drug targets
- MeSH terms
- Adenosine Triphosphatases, Antineoplastic Agents, Hot Temperature, Humans, Ligands, Protein Binding, Protein Denaturation, K562 Cells, Proteome, Proteomics, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.